Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Nasopharyngeal Carcinoma × Epirubicin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Resectable HER2-positive Breast Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Carcinoma, Adenoid Cystic 1

Interventions

Cisplatin 12 Specimen Handling 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Radiotherapy, Intensity-Modulated 6 Platinum 5 Capecitabine 5 1,2-diaminocyclohexaneplatinum II citrate 5 pembrolizumab 4 Radiotherapy 4 Nivolumab 4 Immunoglobulin G 3 Docetaxel 3 Disulfides 3 toripalimab 2 tislelizumab 2 spartalizumab 2 camrelizumab 2 atezolizumab 2 Drug Therapy 2 Carboplatin 2 Biopsy 2 Bevacizumab 2 streptococcal preparation 722 1 sintilimab 1 relatlimab 1 fludarabine 1 fluciclovine F-18 1 envafolimab 1 dehydroftorafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡